Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial

Detalles Bibliográficos
Autores principales: Crowley, Matthew J., McGuire, Darren K., Alexopoulos, Anastasia-Stefania, Jensen, Thomas Jon, Rasmussen, Søren, Saevereid, Hans A., Verma, Subodh, Buse, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440910/
https://www.ncbi.nlm.nih.gov/pubmed/32647053
http://dx.doi.org/10.2337/dc20-0437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440910/
https://www.ncbi.nlm.nih.gov/pubmed/32647053
http://dx.doi.org/10.2337/dc20-0437

Ejemplares similares